There were 2,378 press releases posted in the last 24 hours and 359,515 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GENFIT: Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image